Comments
Loading...

Cyclo Therapeutics

CYTHNASDAQ
Logo brought to you by Benzinga Data
$0.699000
-0.0098-1.38%
At close: -
$0.665000
-0.03-4.86%
After Hours: Nov 20, 9:29 AM EDT
Consensus Rating1
Neutral
Highest Price Target1
$0.95
Lowest Price Target1
$0.95
Consensus Price Target1
$0.95

Cyclo Therapeutics (NASDAQ:CYTH) Stock, Analyst Ratings, Price Targets, Forecasts

Cyclo Therapeutics Inc has a consensus price target of $0.95 based on the ratings of 3 analysts. The high is $0.95 issued by Ascendiant Capital on August 26, 2024. The low is $0.95 issued by Ascendiant Capital on August 26, 2024. The 3 most-recent analyst ratings were released by Ascendiant Capital, HC Wainwright & Co., and HC Wainwright & Co. on August 26, 2024, August 23, 2024, and August 16, 2024, respectively. With an average price target of $1.63 between Ascendiant Capital, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 145.61% upside for Cyclo Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
May
2
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Ascendiant Capital
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Cyclo Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Cyclo Therapeutics (CYTH) stock?

A

The latest price target for Cyclo Therapeutics (NASDAQ:CYTH) was reported by Maxim Group on August 27, 2024. The analyst firm set a price target for $0.00 expecting CYTH to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cyclo Therapeutics (CYTH)?

A

The latest analyst rating for Cyclo Therapeutics (NASDAQ:CYTH) was provided by Maxim Group, and Cyclo Therapeutics downgraded their hold rating.

Q

When was the last upgrade for Cyclo Therapeutics (CYTH)?

A

The last upgrade for Cyclo Therapeutics Inc happened on September 27, 2023 when Maxim Group raised their price target to $4. Maxim Group previously had a hold for Cyclo Therapeutics Inc.

Q

When was the last downgrade for Cyclo Therapeutics (CYTH)?

A

The last downgrade for Cyclo Therapeutics Inc happened on August 27, 2024 when Maxim Group changed their price target from N/A to N/A for Cyclo Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Cyclo Therapeutics (CYTH)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cyclo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cyclo Therapeutics was filed on August 27, 2024 so you should expect the next rating to be made available sometime around August 27, 2025.

Q

Is the Analyst Rating Cyclo Therapeutics (CYTH) correct?

A

While ratings are subjective and will change, the latest Cyclo Therapeutics (CYTH) rating was a downgraded with a price target of $0.00 to $0.00. The current price Cyclo Therapeutics (CYTH) is trading at is $0.67, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch